134 results
8-K
TXMD
TherapeuticsMD Inc
5 Dec 22
TherapeuticsMD Announces Definitive Agreements to License its Products to Mayne Pharma
7:31am
the initial $140.0 million payment to the Company from cash and existing debt facilities and through a binding commitment from Rubric Capital Management
8-K
EX-10.1
zwmku20sop gd6t0tiro
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.2
rt8pgxff k3senflw8m
31 Oct 22
TherapeuticsMD Announces Additional $7 Million Private Placement
7:00am
8-K
EX-10.1
2wdyz9376ase
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.2
bh94w
3 Oct 22
TherapeuticsMD Announces $7 Million Private Placement
7:00am
8-K
EX-10.1
bfkgu6ymvra40k6inm6
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
8-K
EX-10.2
ueh98n8w1r
1 Aug 22
TherapeuticsMD Secures $15 Million Equity Investment from Rubric Capital
6:55am
SC TO-T/A
obju5
6 Jul 22
Third party tender offer statement (amended)
6:23am
SC TO-T/A
EX-99
fq0bx0a5ryio2sr4g6ux
6 Jul 22
Third party tender offer statement (amended)
6:23am
SC 14D9
ptx wn1b51ygz
10 Jun 22
Tender offer solicitation
6:51pm
SC TO-T
EX-99
58c0i fzt9d
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-T
EX-99
vmrbpqrpjel3am9
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-T
te8n66nvxrzl uylm
6 Jun 22
Third party tender offer statement
5:02pm
SC TO-T
EX-99
esj4n0ezzq4lqt4y zj
6 Jun 22
Third party tender offer statement
5:02pm